Cargando…

Soluble Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 as a Biochemical Marker for Atherosclerosis-Related Diseases

Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1), the main oxidized low-density lipoprotein (OxLDL) in endothelial cells, is upregulated in atherosclerotic lesions and is involved in several cellular processes that regulate the pathogenesis of atherosclerosis. The LOX-1 expressed on t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pirillo, Angela, Catapano, Alberico Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3809739/ https://www.ncbi.nlm.nih.gov/pubmed/24198442 http://dx.doi.org/10.1155/2013/716325

Ejemplares similares

High density lipoproteins and atherosclerosis: emerging aspects
por: Sala, Federica, et al.
Publicado: (2012)

LOX-1, OxLDL, and Atherosclerosis
por: Pirillo, Angela, et al.
Publicado: (2013)

Twelve Variants Polygenic Score for Low‐Density Lipoprotein Cholesterol Distribution in a Large Cohort of Patients With Clinically Diagnosed Familial Hypercholesterolemia With or Without Causative Mutations
por: Olmastroni, Elena, et al.
Publicado: (2022)

Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Level is Related to Clinical Prognosis In Patients with Acute Atherosclerosis-related Ischemic Stroke
por: Yang, Xiaoli, et al.
Publicado: (2021)

Serum Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1) Is Associated with Atherosclerosis Severity in Coronary Artery Disease
por: Kott, Katharine A., et al.
Publicado: (2023)

Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Is Inversely Correlated with the Activity of ANCA-Associated Vasculitis
por: Yoon, Taejun, et al.
Publicado: (2020)

Update on the management of severe hypertriglyceridemia – focus on free fatty acid forms of omega-3
por: Pirillo, Angela, et al.
Publicado: (2015)

Inclisiran: How Widely and When Should We Use It?
por: Pirillo, Angela, et al.
Publicado: (2022)

Association between soluble lectin-like oxidized low-density lipoprotein receptor 1 levels and coronary slow flow phenomenon
por: Caglar, Ilker Murat, et al.
Publicado: (2016)

Effect of Lipids and Lipoproteins on Hematopoietic Cell Metabolism and Commitment in Atherosclerosis
por: Baragetti, Andrea, et al.
Publicado: (2021)

Association of circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 with inflammatory markers and urinary albumin excretion in patients with type 2 diabetes
por: Takebayashi, Kohzo, et al.
Publicado: (2021)

Plasma soluble lectin-like oxidized low-density lipoprotein receptor-1 acts as a new biomarker for NSTEMI and STEMI patients
por: Sheikh, Md Sayed Ali
Publicado: (2022)

Role of Lectin-Like Oxidized Low Density Lipoprotein-1 in Fetoplacental Vascular Dysfunction in Preeclampsia
por: Zuniga, Felipe A., et al.
Publicado: (2014)

Oxidized low density lipoprotein, stem cells, and atherosclerosis
por: Yang, Hui, et al.
Publicado: (2012)

Are oxidized low-density lipoprotein and C-reactive protein markers of atherosclerosis in nephrotic children?
por: Rybi-Szumińska, A., et al.
Publicado: (2014)

Lectin-like oxidized low-density lipoprotein receptor 1 attenuates pneumonia-induced lung injury
por: Korkmaz, Filiz T., et al.
Publicado: (2022)

Pregnancy Followed by Delivery May Affect Circulating Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels in Women of Reproductive Age
por: Balin, Mehmet, et al.
Publicado: (2012)

High Levels of Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Acute Stroke: An Age- and Sex-Matched Cross-Sectional Study
por: Yokota, Chiaki, et al.
Publicado: (2016)

Serum soluble lectin‐like oxidized low‐density lipoprotein receptor‐1 as a biomarker of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
por: Lin, Qun, et al.
Publicado: (2020)

Role of Plasma Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 and microRNA-98 in Severity and Risk of Coronary Artery Disease
por: Sheikh, Md Sayed Ali
Publicado: (2021)

New insights into the role of bempedoic acid and ezetimibe in the treatment of hypercholesterolemia
por: Pirillo, Angela, et al.
Publicado: (2022)

Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives
por: Catapano, Alberico Luigi, et al.
Publicado: (2017)

Effect of oral magnesium sulfate administration on lectin‐like oxidized low‐density lipoprotein receptor‐1 gene expression to prevent atherosclerosis in diabetic rat vessels
por: Fazlali, Mina, et al.
Publicado: (2018)

The Role of Oxidized Low-Density Lipoproteins in Atherosclerosis: The Myths and the Facts
por: Maiolino, Giuseppe, et al.
Publicado: (2013)

Mechanistic Insights into the Oxidized Low-Density Lipoprotein-Induced Atherosclerosis
por: Khatana, Chainika, et al.
Publicado: (2020)

Serum Levels of Carbamylated LDL and Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated with Coronary Artery Disease in Patients with Metabolic Syndrome
por: Stankova, Teodora, et al.
Publicado: (2019)

High Plasma Levels of Soluble Lectin‐like Oxidized Low‐Density Lipoprotein Receptor‐1 Are Associated With Inflammation and Cardiometabolic Risk Profiles in Pediatric Overweight and Obesity
por: Stinson, Sara E., et al.
Publicado: (2023)

Inhibition of the lectin-like oxidized low-density lipoprotein receptor-1 improves intestinal microcirculation in experimental endotoxaemia
por: Lehmann, C, et al.
Publicado: (2009)

Low-density lipoprotein particles in atherosclerosis
por: Qiao, Ya-Nan, et al.
Publicado: (2022)

Circulating Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1): A Diagnostic Indicator across the Spectrum of Acute Coronary Syndrome
por: Kumar, Sandeep, et al.
Publicado: (2021)

Increased Levels of Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor‐1 in Ischemic Stroke and Transient Ischemic Attack
por: Skarpengland, Tonje, et al.
Publicado: (2018)

Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results
por: Vavere, Andrea L., et al.
Publicado: (2023)

Smoking cessation reduces the lectin-like low-density lipoprotein receptor index, an independent cardiovascular risk marker of vascular inflammation
por: Komiyama, Maki, et al.
Publicado: (2017)

High-density lipoprotein revisited: biological functions and clinical relevance
por: von Eckardstein, Arnold, et al.
Publicado: (2022)

The Association of Proprotein Convertase Subtilisin/Kexin Type 9 to Plasma Low-Density Lipoproteins: An Evaluation of Different Methods
por: Canclini, Laura, et al.
Publicado: (2021)

Cysteamine Decreases Low‐Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low‐Density Lipoprotein Receptor–Deficient Mice
por: Ahmad, Feroz, et al.
Publicado: (2021)

Soluble lectin‐like oxidized low‐density Lipoproteinreceptor‐1 and recurrent stroke: A nested case–control study
por: Wang, Anxin, et al.
Publicado: (2022)

Lectin-like, oxidized low-density lipoprotein receptor-1-deficient mice show resistance to age-related knee osteoarthritis
por: Hashimoto, Kazuhiko, et al.
Publicado: (2017)

Correction to: Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results
Publicado: (2023)

Monoclonal Antibodies in the Management of Familial Hypercholesterolemia: Focus on PCSK9 and ANGPTL3 Inhibitors
por: Pirillo, Angela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c13pra3jtkekgvqs84odqhbbpt